Effects of phentermine on striatal dopamine and serotonin release in conscious rats: In vivo microdialysis study

International Journal of Obesity

Volumn 22, Issue 4, 1998, Pages 325-328

  Balcioglu, A ^a   Wurtman, R J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Dopamine; Microdialysis; Phentermine; Serotonin; Striatum

Indexed keywords

AMPHETAMINE; ANOREXIGENIC AGENT; DOPAMINE; NEUROTRANSMITTER; PHENTERMINE; SEROTONIN; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

ANIMALIA;

EID: 0031908645     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800589     Document Type: Article

References (23)

1. Garattini S, Samanin R. Anorectic drugs and brain neurotransmitters. In: Silverstone T. (ed) Dahlem Workshop on appetite and food intake. Abakon: Berlin, 1976, 83-108.
2. Dobrzanski S, Doggett NS. The effect of propranolol, phentolamine and pimozidc on drug-induced anorexia in the mouse. Psychopharmacology 1979; 66: 297-300.
3. Samanin R, Bernasconi S, Garattini S. The effect of selective lesioning of brain catecholamine-containing neurons on the activity of various anorectics in the rat. Eur J Pharmacol 1975; 34: 373-375.
4. Yelnosky J, Panasevich RE, Borrelli AR, Lawlor RB. Pharmacology of phentermine. Arch Int Pharmacodyn 1969; 178: 62-76.
5. Lawlor RB, Trivedi MC, Yelnosky J. A determination of the anorexigenic potential of dl-amphetamine, d-amphetemine, I-amphetamine and phentermine. Arch Int Pharmacodyn 1969; 179: 401-407.
6. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. A double -blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Int Med 1984; 144: 1143-1148.
7. Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, Lasagna L, Cox C. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 1992; 51: 586-594.
8. Garattini S, Borroni E, Mennini T, Samanin R. Differences and similarities between anorectic agents. In: Garattini S, Samanin R (eds) Central mechanisms of anorectic drugs. Raven Press: New York, 1978, 127-143.
9. Spedding M, Ouvry C, Millan M, Duhault J, Dacquet C, Wurtman R. Neural control of dieting. Nature 1996; 380: 488.
10. Bettini E, Ceci A, Spinelli R, Samanin R. Neuroleptic-like effects of the I-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochem Pharmacol 1987; 36: 2387-2391.
11. Tossman U, Ungerstedt U. Microdialysis in the study of extracellular levels of aminoacids in the rat brain. Acta Physiol Scand 1986; 128: 9-14.
12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. (2nd edn). Academic Press: Sydney, 1986.
13. Westerink BHC, Hofsteede RM, Tuntler J, de Vries JB. Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J Neurochem 1989; 52: 722-729.
14. Westerink BHC, Tuntler G, Damsma G, Rollema H, de Vries JB. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 1997; 336: 502-507.
15. Ichikawa J, Meltzer HY. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res 1995; 698: 204-208.
16. Hernandez L, Lee F, Hoebel BG. Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats; increase in extracellular dopamine and serotonin. Brain Res Bull 1987; 19: 623-628.
17. Raiteri M, Bonanno G, Vallebuona F. In vitro and in vivo effects of d-fenfluramine: No apparent relation between 5-hydroxytryptamine release and hypophagia. J Pharmacol Exp Ther 1995; 273: 643-649.
18. Uretsky NJ, Iversen LL. Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem 1970; 17: 269-278.
19. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS. Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 1975; 10: 241-323.
20. Sabol KE, Richards JB, Freed CR. In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill, Pharmacol Biochem Behav 1990; 36: 21-28.
21. Acworth IN, During MJ, Wurtman RJ. Tyrosine: Effects on catecholamine release. Brain Res Bull 1988; 21: 473-477.
22. Sharp T, Bramwell SR, Clark D, Grahame-Smith DG. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem 1989; 53: 234-240.
23. Saito H., Matsumoto M, Togashi H, Yoshioka M. Functional interaction between serotonin and other neuronal systems: Focus on in vivo microdialysis studies. Jpn J Pharmacol 1996; 70: 203-225.